Treatment cost of non-small cell lung cancer in three European countries: comparisons across France, Germany, and England using administrative databases

Abstract

Considerable differences in average treatment costs were observed. In-patient costs dominate in the first year of treatment in all countries. The study highlights the costly nature of NSCLC.